Ameritas Investment Partners Inc. Has $2.08 Million Holdings in West Pharmaceutical Services, Inc. (WST)

Ameritas Investment Partners Inc. raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 1.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 22,011 shares of the medical instruments supplier’s stock after purchasing an additional 415 shares during the period. Ameritas Investment Partners Inc.’s holdings in West Pharmaceutical Services were worth $2,080,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in WST. BlackRock Inc. increased its stake in shares of West Pharmaceutical Services by 8,884.7% during the first quarter. BlackRock Inc. now owns 5,805,036 shares of the medical instruments supplier’s stock valued at $473,749,000 after purchasing an additional 5,740,426 shares in the last quarter. Riverbridge Partners LLC bought a new position in shares of West Pharmaceutical Services during the second quarter valued at approximately $48,340,000. Vanguard Group Inc. increased its stake in shares of West Pharmaceutical Services by 6.5% during the first quarter. Vanguard Group Inc. now owns 6,440,844 shares of the medical instruments supplier’s stock valued at $525,637,000 after purchasing an additional 392,516 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of West Pharmaceutical Services by 7,670.7% during the second quarter. Renaissance Technologies LLC now owns 318,600 shares of the medical instruments supplier’s stock valued at $30,114,000 after purchasing an additional 314,500 shares in the last quarter. Finally, FMR LLC increased its stake in shares of West Pharmaceutical Services by 198.9% during the second quarter. FMR LLC now owns 388,625 shares of the medical instruments supplier’s stock valued at $36,733,000 after purchasing an additional 258,611 shares in the last quarter. 90.57% of the stock is owned by institutional investors and hedge funds.

A number of brokerages have weighed in on WST. Stephens began coverage on shares of West Pharmaceutical Services in a research note on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 target price for the company. Zacks Investment Research raised shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Wednesday, September 27th. Jefferies Group LLC raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and raised their target price for the company from $96.00 to $115.00 in a research note on Friday, September 15th. Finally, BidaskClub downgraded shares of West Pharmaceutical Services from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $107.00.

ILLEGAL ACTIVITY WARNING: “Ameritas Investment Partners Inc. Has $2.08 Million Holdings in West Pharmaceutical Services, Inc. (WST)” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/2957665/ameritas-investment-partners-inc-has-2-08-million-holdings-in-west-pharmaceutical-services-inc-wst.html.

Shares of West Pharmaceutical Services, Inc. (NYSE:WST) traded down 0.08% during trading on Friday, hitting $94.98. 23,173 shares of the company’s stock were exchanged. West Pharmaceutical Services, Inc. has a one year low of $70.17 and a one year high of $99.91. The firm has a 50-day moving average price of $92.22 and a 200-day moving average price of $91.12. The stock has a market cap of $7.03 billion, a P/E ratio of 40.76 and a beta of 1.12.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The company had revenue of $397.60 million during the quarter, compared to analysts’ expectations of $406.00 million. During the same quarter in the prior year, the company posted $0.59 earnings per share. West Pharmaceutical Services’s revenue for the quarter was up 2.5% compared to the same quarter last year. Equities research analysts expect that West Pharmaceutical Services, Inc. will post $2.68 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 1st. Shareholders of record on Wednesday, October 18th will be paid a dividend of $0.14 per share. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date is Tuesday, October 17th. This represents a $0.56 dividend on an annualized basis and a yield of 0.59%. West Pharmaceutical Services’s dividend payout ratio is presently 22.22%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.